The FDA approval of Ervebo comes shortly after another Ebola vaccine developed by Johnson & Johnson and Bavarian Nordic, known as Ad26.ZEBOV/MVA-BN-Filo, was filed for approval in Europe.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...